Amiloride differs from spironolactone in that :
**Core Concept**
Amiloride and spironolactone are both potassium-sparing diuretics used in the treatment of hypertension and edema. However, they work through different mechanisms to achieve this effect. Amiloride is a direct blocker of the epithelial sodium channel (ENaC) in the collecting duct, whereas spironolactone is a competitive antagonist of the mineralocorticoid receptor.
**Why the Correct Answer is Right**
Amiloride works by directly blocking the ENaC, which is responsible for sodium reabsorption in the collecting duct. By blocking ENaC, amiloride reduces sodium reabsorption, increases sodium excretion, and consequently, decreases potassium secretion, leading to potassium sparing. In contrast, spironolactone acts by binding to the mineralocorticoid receptor, which is activated by aldosterone. By blocking the mineralocorticoid receptor, spironolactone reduces sodium reabsorption and potassium secretion in the collecting duct.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not specify the mechanism by which amiloride differs from spironolactone. Amiloride's action on ENaC is distinct from spironolactone's action on the mineralocorticoid receptor.
* **Option B:** This option is incorrect because it does not accurately describe the difference between amiloride and spironolactone. Amiloride is not a potassium channel opener, and spironolactone is not a direct blocker of ENaC.
* **Option C:** This option is incorrect because it does not accurately describe the difference between amiloride and spironolactone. Amiloride is not a thiazide-like diuretic, and spironolactone is not a direct blocker of the sodium-potassium pump.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that potassium-sparing diuretics like amiloride and spironolactone can cause hyperkalemia, especially in patients with renal insufficiency. Regular monitoring of potassium levels is crucial when using these medications.
**Correct Answer: C. Amiloride is a direct blocker of the epithelial sodium channel (ENaC), whereas spironolactone is a competitive antagonist of the mineralocorticoid receptor.**